Skip to main content
Clinical Trials/NCT06160986
NCT06160986
Active, not recruiting
Not Applicable

Multidisciplinary Intervention for Adults With Chronic Graft Versus Host Disease

University of Miami1 site in 1 country20 target enrollmentStarted: December 27, 2023Last updated:

Overview

Phase
Not Applicable
Status
Active, not recruiting
Enrollment
20
Locations
1
Primary Endpoint
Percentage of participant retention

Overview

Brief Summary

This research is being done to evaluate the feasibility of the Horizons Program, a group-based behavioral intervention, to enhance quality of life in patients with chronic graft-versus-host disease.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
21 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • underwent allogeneic hematopoietic stem cell transplant
  • have moderate to severe chronic graft versus host disease
  • currently receiving care at the Sylvester Comprehensive Cancer Center Bone Marrow Transplant Program
  • able to participate in a group intervention in English or Spanish language

Exclusion Criteria

  • comorbid conditions or cognitive impairment that the treating clinician believes prohibits informed consent or participation in the intervention
  • vulnerable patients, defined here as prisoners and pregnant women

Arms & Interventions

Horizons Group

Experimental

Participants will receive the Horizons Group intervention for up to 8 weeks.

Intervention: Horizons Group Intervention (Behavioral)

Outcomes

Primary Outcomes

Percentage of participant retention

Time Frame: Baseline (pre-intervention) to 10-week follow-up

Participant retention will be demonstrated if ≥80% participants are retained in the study at week 10.

Percentage of participant enrollment

Time Frame: Baseline (pre-intervention) to 10-week follow-up

Participant enrollment will be demonstrated if ≥50% eligible participants enroll

Percentage of participant attendance

Time Frame: Baseline (pre-intervention) to 10-week follow-up

Participant attendance will be demonstrated if ≥80% participants complete ≥4 of 8 sessions

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Lara Traeger

Associate Professor

University of Miami

Study Sites (1)

Loading locations...

Similar Trials